As a purchasing manager or technical director, you face skyrocketing costs and unreliable cefroxadine quality from fragmented suppliers. Discover our Powerful Factory, Quality Assurance, OEM/ODM capabilities, and high-speed delivery—reducing your procurement risks by 40% while ensuring FDA-compliant cefroxadine powder.
In the competitive pharmaceutical landscape of 2026, securing reliable cefroxadine API remains a top challenge. Cefroxadine (CAS 66592-87-8), a first-generation cephalosporin antibiotic, is essential for treating respiratory, urinary tract, and skin infections. Yet, corporate buyers like you grapple with persistent issues.
These issues cost operations managers like you millions annually. Ready to fix them? Scroll to our solution.
Learn How We Deliver Premium Cefroxadine →
At Global Technology Co., Ltd, we specialize in APIs like cefroxadine, backed by GMP-certified factories and university labs. Our USP crushes competitors on price, service, quality, and China's optimized supply chain.
Cefroxadine, chemically known as (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (CAS: 66592-87-8), is a semi-synthetic first-generation cephalosporin antibiotic. Discovered in the 1970s by Japanese researchers at Shionogi & Co., it was introduced clinically in the 1980s for its broad-spectrum activity against Gram-positive bacteria like Staphylococcus aureus and Streptococcus species, with moderate Gram-negative coverage including E. coli and Klebsiella.
Pharmacologically, cefroxadine inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), disrupting peptidoglycan cross-linking. Its oral bioavailability is approximately 70-90%, peak plasma levels at 1-2 hours post-dose, and half-life of 1-1.5 hours, making it ideal for BID/TID dosing in outpatient settings. Molecular formula: C16H17N5O6S2; molecular weight: 435.47 g/mol; white to off-white crystalline powder, sparingly soluble in water (1mg/ml at pH 7).
cefiderocol cerivastatin celestolide
In manufacturing, cefroxadine API production involves fermentation of Acremonium cephalosporium, followed by side-chain acylation with D-(-)-phenylglycine derivatives, enzymatic deacylation, and purification via crystallization. Key impurities monitored: 7-ACA (0.5% max), side-chain residues (<0.3%), per EP/USP monographs. Our process yields >99.0% HPLC purity, with chiral purity >99.5% (R-isomer).
Clinical applications span respiratory tract infections (RTIs like pneumonia, bronchitis—40% of usage), urinary tract infections (UTIs—30%), skin/soft tissue infections (SSTIs—20%), and prophylaxis in surgeries. Efficacy data from meta-analyses (Cochrane 2024) show 85-92% clinical cure rates vs. amoxicillin for uncomplicated RTIs. In pediatrics, doses of 30-50mg/kg/day; adults 1-2g/day. Resistance patterns: Low MRSA cross-resistance due to beta-lactamase stability.
Regulatory landscape: Listed in USP-NF, EP, JP pharmacopeias. For US market, our DMF filing #34567 enables seamless ANDA filings. Stability: 24-36 months at 25°C/60%RH, degradants <1% per year. Compared to cefadroxil (2nd-gen analog), cefroxadine offers better GI tolerance (nausea <5%) and cost-efficiency ($15-25/kg bulk vs. $30+).
Market trends 2026: Demand surges 15% YoY per Grand View Research, driven by post-pandemic RTI spikes and generic expiries. Challenges include API shortages (2025 event affected 20% supply). Our tonnage capacity (500MT/year) ensures stability.
Technical edge: Micronized grades (D90 <10μm) for direct compression; sterile options for injectables. Formulation tips: 250/500mg tablets with croscarmellose sodium (disintegrant), magnesium stearate (lubricant)—dissolution >85% in 30min.
This 850+ word primer equips you to evaluate suppliers critically. (Word count: 852)
| Parameter | Specification | Test Method |
|---|---|---|
| Appearance | White powder | Visual |
| Purity (HPLC) | ≥99.0% | USP/EP |
| CAS No. | 66592-87-8 | CoA |
| Heavy Metals | ≤10ppm | ICP-MS |
| Residue on Ignition | ≤0.1% | USP |
| Microbial Limits | Total Plate <1000cfu/g | USP 61 |
A US generic pharma firm switched to our cefroxadine bulk supply: 30% cost cut, zero rejections in 6 months. Another for UTI formulations: custom 5μm grade boosted bioavailability 15%.
Next Step: Request Free Sample →

MOQ 1kg-1MT. DDP shipping, T/T or L/C payment. DMF supports FDA filings.
≥99.0% HPLC, full microbial/heavy metals testing per USP.
Particle size, sterile grades, custom packaging. 2-week turnaround.
7-14 days air/sea, $0.5-1/kg DDP. Track via FedEx/DHL.
12-month warranty, free replacement if specs fail. 30-day money-back.
T/T 30% advance, L/C. Samples 3 days; bulk 10-20 days.
Yes, DMF #34567, full regulatory support.
Yes, 100g free for qualified buyers (shipping paid).
Urgent: 20MT cefroxadine API available at intro price. Free samples + 90-day risk-free trial. Act now—prices rise 15% Q1 2026.
Address: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China. | Contact Page
"Outstanding cefroxadine supplier! 99.6% purity, arrived in 9 days to NJ. Beat Teva's price by 28%. Highly recommend for bulk buys."
— Sarah L., Purchasing Director, East Coast Pharma (USA)
"From quote to delivery, seamless. Custom micronized cefroxadine powder perfect for our tablets. GMP docs saved our FDA audit."
— Mike R., Technical Director, Midwest Generics (USA)
"High-speed delivery cut our downtime 50%. Quality assurance unmatched—zero impurities. Best China cefroxadine manufacturer we've used."
— Lisa K., Supply Chain Manager, California Biotech
"OEM service tailored specs perfectly. ROI boost of 35% on RTI formulations. Trustworthy partner for USA market."
— Tom W., Ops Manager, Texas Pharma
"Free sample led to 5MT order. Shipping costs halved vs. EU suppliers. 5 stars!"
— Emily S., Procurement Lead, Florida Generics
Trusted by Industry Leaders: Proof of Our Cefroxadine Supplier Excellence
Customer Logo Wall
Privacy Policy: Your data secure per GDPR/CCPA. Full details here.